PACB (Pacific Biosciences of California) E10: $-1.12 (As of Mar. 2026)


PACB Pacific Biosciences of California Inc PACB
53 GF Score
Price $1.60
GF Value $1.62
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Pacific Biosciences of California E10?

Pacific Biosciences of California PACB +11.11% 53 E10 is $-1.12 as of Mar. 2026. GuruFocus rates PACB with a GF Score™ of 53/100 and a GF Value™ of $1.62 (Fairly Valued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Pacific Biosciences of California's adjusted earnings per share data for the three months ended in Mar. 2026 was $-0.030. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-1.12 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was -6.70% per year. During the past 5 years, the average E10 Growth Rate was -1.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Pacific Biosciences of California was 62.50% per year. The lowest was -6.70% per year. And the median was 1.30% per year.

As of today (2026-06-26), Pacific Biosciences of California's current stock price is $1.60. Pacific Biosciences of California's E10 for the quarter that ended in Mar. 2026 was $-1.12. Pacific Biosciences of California's Shiller PE Ratio of today is .


Pacific Biosciences of California  (NAS:PACB) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Pacific Biosciences of California E10 Related Terms


Pacific Biosciences of California E10 Historical Data

* Premium members only.

The historical data trend for Pacific Biosciences of California's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pacific Biosciences of California E10 Chart

Pacific Biosciences of California Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.94 -0.93 -0.91 -0.98 -1.13

Pacific Biosciences of California Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.10 -1.10 -1.12 -1.13 -1.12

PACB vs CATX, LAB, KIDS: E10 Comparison

For the Medical Devices subindustry, Pacific Biosciences of California's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pacific Biosciences of California Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pacific Biosciences of California's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pacific Biosciences of California's Shiller PE Ratio falls into.


PACB
53GF Score
Pacific Biosciences of California Inc PACB
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pacific Biosciences of California E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pacific Biosciences of California's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.03/330.2130*330.2130
=-0.030

Current CPI (Mar. 2026) = 330.2130.

Pacific Biosciences of California Quarterly Data

per share eps CPI Adj_EPS
201606 -0.210 241.018 -0.288
201609 -0.190 241.428 -0.260
201612 -0.200 241.432 -0.274
201703 -0.260 243.801 -0.352
201706 -0.260 244.955 -0.350
201709 -0.190 246.819 -0.254
201712 -0.180 246.524 -0.241
201803 -0.200 249.554 -0.265
201806 -0.170 251.989 -0.223
201809 -0.190 252.439 -0.249
201812 -0.210 251.233 -0.276
201903 -0.200 254.202 -0.260
201906 -0.160 256.143 -0.206
201909 -0.190 256.759 -0.244
201912 -0.001 256.974 -0.001
202003 0.010 258.115 0.013
202006 -0.150 257.797 -0.192
202009 -0.140 260.280 -0.178
202012 0.370 260.474 0.469
202103 -0.450 264.877 -0.561
202106 -0.210 271.696 -0.255
202109 0.080 274.310 0.096
202112 -0.310 278.802 -0.367
202203 -0.370 287.504 -0.425
202206 -0.320 296.311 -0.357
202209 -0.340 296.808 -0.378
202212 -0.370 296.797 -0.412
202303 -0.360 301.836 -0.394
202306 -0.280 305.109 -0.303
202309 -0.260 307.789 -0.279
202312 -0.310 306.746 -0.334
202403 -0.290 312.332 -0.307
202406 -0.640 314.175 -0.673
202409 -0.220 315.301 -0.230
202412 -0.490 315.605 -0.513
202503 -1.440 319.799 -1.487
202506 -0.140 322.561 -0.143
202509 -0.130 324.800 -0.132
202512 -0.130 324.054 -0.132
202603 -0.030 330.213 -0.030

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-1.12 mean?
Pacific Biosciences of California (PACB) has a E10 of $-1.12 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Pacific Biosciences of California and its competitors.
Is Pacific Biosciences of California's E10 too high?
Pacific Biosciences of California's current E10 is $-1.12. Overall, Pacific Biosciences of California has a GF Score™ of 53/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pacific Biosciences of California's E10 compare to CATX and LAB?
Pacific Biosciences of California's E10 of $-1.12 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Pacific Biosciences of California and its competitors. Pacific Biosciences of California's current E10 is $-1.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pacific Biosciences of California stock overvalued right now?
Based on GuruFocus' analysis, Pacific Biosciences of California (PACB) is currently considered Fairly Valued. The stock's GF Value™ is $1.62, compared to a current price of $1.60 — trading 1.2% below its estimated fair value. The current E10 is $-1.12. Pacific Biosciences of California's overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Pacific Biosciences of California (PACB), the current E10 is $-1.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pacific Biosciences of California (PACB) Overvalued in 2026?

Based on GuruFocus' analysis, Pacific Biosciences of California stock appears to be undervalued. The current stock price of $1.60 is trading 1.2% below its estimated GF Value™ of $1.62. GuruFocus considers Pacific Biosciences of California to be Fairly Valued.

Key valuation signals for PACB:

  • E10: $-1.12
  • GF Value™: $1.62 vs. price of $1.60 (1.2% below fair value)
  • GF Score™: 53/100 with 8 warning signs

No single metric tells the full story. See the PACB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pacific Biosciences of California Business Description

Other Exchanges P09:Germany
Address 1305 O’Brien Drive, Menlo Park, CA, USA, 94025
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
53GF Score

Get the complete analysis for PACB

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.60
Price
$1.62
GF Value